Literature DB >> 10361623

A vaginal fluid simulant.

D H Owen1, D F Katz.   

Abstract

A fluid medium was developed to simulate the fluid produced in the human vagina. The composition of the medium was based on an extensive review of the literature on constituents of human vaginal secretions. In choosing the ingredients for this medium, the goal was to emphasize properties that influence interactions of vaginal fluid with topical contraceptive, prophylactic, or therapeutic products. Among these properties, pH and osmolarity play a dominant role in physicochemical processes that govern drug release and distribution.

Entities:  

Keywords:  Biology; Clinical Research; Drugs; Genitalia; Genitalia, Female; Physiology; Research Methodology; Research Report; Treatment; Urogenital System; Vagina

Mesh:

Substances:

Year:  1999        PMID: 10361623     DOI: 10.1016/s0010-7824(99)00010-4

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  201 in total

1.  A Dose Ranging Pharmacokinetic Evaluation of IQP-0528 Released from Intravaginal Rings in Non-Human Primates.

Authors:  Jonathan T Su; Ryan S Teller; Priya Srinivasan; Jining Zhang; Amy Martin; Samuel Sung; James M Smith; Patrick F Kiser
Journal:  Pharm Res       Date:  2017-08-02       Impact factor: 4.200

2.  Submicron Matrices Embedded in a Polymeric Caplet for Extended Intravaginal Delivery of Zidovudine.

Authors:  Felix Mashingaidze; Yahya E Choonara; Pradeep Kumar; Lisa C du Toit; Vinesh Maharaj; Eckhart Buchmann; Viness Pillay
Journal:  AAPS J       Date:  2017-08-04       Impact factor: 4.009

3.  Polymeric nanoparticles affect the intracellular delivery, antiretroviral activity and cytotoxicity of the microbicide drug candidate dapivirine.

Authors:  José das Neves; Johan Michiels; Kevin K Ariën; Guido Vanham; Mansoor Amiji; Maria Fernanda Bahia; Bruno Sarmento
Journal:  Pharm Res       Date:  2011-11-10       Impact factor: 4.200

4.  Protection of mice from a Chlamydia trachomatis vaginal infection using a Salicylidene acylhydrazide, a potential microbicide.

Authors:  Anatoly Slepenkin; Hencelyn Chu; Mikael Elofsson; Pia Keyser; Ellena M Peterson
Journal:  J Infect Dis       Date:  2011-09-20       Impact factor: 5.226

5.  Sensitive and rapid HPLC quantification of tenofovir from hyaluronic acid-based nanomedicine.

Authors:  Vivek Agrahari; Bi-Botti C Youan
Journal:  AAPS PharmSciTech       Date:  2012-01-04       Impact factor: 3.246

Review 6.  Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective.

Authors:  Rebecca M Brotman
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

7.  The effects of inhomogeneous boundary dilution on the coating flow of an anti-HIV microbicide vehicle.

Authors:  Savas Tasoglu; Jennifer J Peters; Su Chan Park; Stéphane Verguet; David F Katz; Andrew J Szeri
Journal:  Phys Fluids (1994)       Date:  2011-09-15       Impact factor: 3.521

8.  Modified silicone elastomer vaginal gels for sustained release of antiretroviral HIV microbicides.

Authors:  Claire J Forbes; Clare F McCoy; Diarmaid J Murphy; A David Woolfson; John P Moore; Abbey Evans; Robin J Shattock; R Karl Malcolm
Journal:  J Pharm Sci       Date:  2014-03-01       Impact factor: 3.534

9.  An intravaginal ring for the sustained delivery of tenofovir disoproxil fumarate.

Authors:  Marc M Baum; Irina Butkyavichene; Scott A Churchman; Gilbert Lopez; Christine S Miller; Thomas J Smith; John A Moss
Journal:  Int J Pharm       Date:  2015-09-16       Impact factor: 5.875

10.  Evaluation of PD 404,182 as an anti-HIV and anti-herpes simplex virus microbicide.

Authors:  Ana M Chamoun-Emanuelli; Michael Bobardt; Bernard Moncla; Marie K Mankowski; Roger G Ptak; Philippe Gallay; Zhilei Chen
Journal:  Antimicrob Agents Chemother       Date:  2013-11-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.